Form 4 for SONM DNA X, Inc.
Accepted 2025-04-02 00:00:00 ET · period of report 2025-03-31 · accession 0001641172-25-002389 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-04-02 | 2025-03-31 | SONM | Steenstra Jack | Dir | A - Grant | $0.00 | +46.7K | 72.5K | +181% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-03-31 | A | A | 46,728 | $0.00 | 72,520 | D | — | — | (F1) Represents the grant of restricted stock units that vest in one installment on the 45th day following the date of the grant, subject to the Reporting Person's continued service to the Issuer. Each restricted stock unit represents the contingent right to receive one share of the Issuer's common stock. (F2) Consists of (i) 14,770 shares of common stock and (ii) 57,750 unvested restricted stock units. |